Here’s a roundup of recent clinical trial news:
- UNC Health Care Researchers, RF Surgical, Report Positive Results from Largest Ever Multi-Center Study on Use of Medical Technology to Help Prevent and Detect Retained Surgical Objects
Researchers from UNC Health Care today reported positive, interim results from the largest ever prospective multi-institution study of any medical device aimed at helping surgical teams prevent and detect retained foreign objects in surgery. The ongoing study examined the use of radio-frequency detection technology (RF Surgical Detection System, RF Surgical) as an adjunct to the standard practice of manual counting.
Read more - Researchers Pool Data to Search for Genetic Risks in Heart Disease
The Coronary ARtery DIsease Genome-wide Replication And Meta-Analysis (CARDIoGRAM) — published in Circulation: Cardiovascular Genetics, an American Heart Association journal — consists of data from every published whole-genome study on genetic mutations in heart attack or CAD risk. Researchers are also pooling data from several unpublished genome-wide association studies to see if any new mutations can be uncovered.
Read more - Orthovita Announces Presentation of Cortoss 24-Month Pivotal Study Results at the 25th Annual Meeting of the North American Spine Society
Orthovita, Inc. (NASDAQ: VITA), an orthobiologics and biosurgery company, is pleased to announce that Hyun W. Bae, M.D., of The Spine Institute at Saint John’s Health Center in Santa Monica, California, will present an abstract entitled, “Correlation of Early Pain and Long-Term Functional Results from a Multi-Center, Prospective, Randomized, Controlled FDA-IDE Vertebroplasty Trial,” at the 25th Annual Meeting of the North American Spine Society (NASS) being held October 5-9, 2010 at the Orange County Convention Center in Orlando, Florida. The presentation will take place on Friday, October 8, 2010 at 7:37 a.m. The abstract has been selected for presentation during the prestigious Friday Best Papers session of the meeting.
Read more - BIOTRONIK: EchoCRT Clinical Trial Design Validated with Recent Publication in European Heart Journal
BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and sponsor of clinical research to advance patient care and evidence-based medicine, announced the publication in the September 23, 2010 issue of the European Heart Journal of a peer-reviewed article that describes the rationale for the echocardiographic methods and dyssynchrony cutoff values selected for the EchoCRT study.
Read more - Study Determines Breast-Specific Gamma Imaging Is More Effective Than Ultrasound in Patients With Complex Breast Tissue
Results of a study on Breast-Specific Gamma Imaging (BSGI) presented at the annual breast meeting of the American Society of Clinical Oncology in Washington, D.C., showed that BSGI was nearly twice as effective in finding cancers and more than three times as likely to lead to the correct diagnosis when compared to ultrasound.
Read more - Presentations from the North American Spine Society’s 25th annual meeting
Presentations include “Indications Critical when Selecting Intervertebral Disc Herniation Treatment;” “Study: True Results of ACDF Do Not Match Perception;” “Surgical Decompression for Cervical Spondylotic Myelopathy is Highly Effective and Safe.”
Read more - Biomoda Extends Pilot Trial on Lung Cancer Diagnostic
Cancer diagnostics company Biomoda, Inc. (OTC BB: BMOD) today announced in its new monthly President’s Column, posted at www.biomoda.com, that it is extending the pilot clinical trial of its CyPath® diagnostic assay for the detection of early-stage lung cancer to recruit additional participants for the positive control group, patients who have been diagnosed with lung cancer but have not yet begun treatment for the disease.
Read more - BSD Medical Reports Published Article Documents Rationale for Increased Use of Hyperthermia
BSD Medical Corp. (NASDAQ: BSDM) today reported that a study titled “Biological Rationales and Clinical Applications of Temperature Controlled Hyperthermia – Implications for Multimodal Cancer Treatments” has been published in Current Medicinal Chemistry (Current Medicinal Chemistry, 2010, 17, 3045-3057). The article, which was authored by leading researchers Schildkopf, Ott, Frey, Wadepohl, Sauer, Fietkau and Gailpl, can be accessed at http://www.bentham.org/cmc/contabs/cmc17-27.htm#5.
Read more - BridgePoint Medical, Inc. Completes and Submits to FDA in the U.S. FAST-CTOs With the CrossBoss and Stingray CTO Recanalization System
BridgePoint Medical, Inc. Completes and Submits to FDA in the U.S. FAST-CTOs With the CrossBoss and Stingray CTO Recanalization System
Read more - DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial
DiFUSION Technologies is a medical device company focused on the development and commercialization of its proprietary CleanFUZE™ anti-microbial technology for orthopedic implants and its new Xiphos™ line of Posterior Interbody products for spinal surgery.
Read more
